Publications by authors named "Roei D Mazor"

Claim this Profile
S
Subunit-Specific Immunodominance in Clinically Distinct Populations With AChR+ Myasthenia Gravis: A Multiparametric Cross-Sectional Analysis.
Kfir Oved, Galit Denkberg, Lena Pinzur, Elisabeth Chroni, Vasiliki Zouvelou, Roei David Mazor

Neurology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibition.
Eli L Diamond, Jean-Francois Emile, Takeshi Fujino, Julien Haroche, Maxim I Maron, Roei D Mazor

Cancer Cell· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cluster analysis reveals the clinical spectrum of Erdheim-Chester disease.
Michelangelo Tesi, Francesco Pegoraro, Francesco Peyronel, Jean-François Emile, Francesco Catamerò, Roei D Mazor

Leukemia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omidubicel-onlv Transplantation for Hematologic Malignancies: Results of a Multicenter Expanded Access Program.
Mitchell E Horwitz, Gary J Schiller, Stephanie B Tsai, Andrew R Rezvani, Richard T Maziarz, Roei D Mazor

Transplant Cell Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy.
Joshua S Friedman, Benjamin H Durham, Anne S Reiner, Mariko Yabe, Kseniya Petrova-Drus, Roei D Mazor

Br J Haematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms.
Benjamin H Durham, Oshrat Hershkovitz-Rokah, Omar Abdel-Wahab, Mariko Yabe, Young Rock Chung, Roei D Mazor

Blood Adv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 Substudy.
Paul Szabolcs, Roei D Mazor, Dima Yackoubov, Stuart Levy, Patrick Stiff

Transplant Cell Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach.
Seyram A Doe-Tetteh, Sabrina Y Camp, Dalicia Reales, Jett Crowdis, Anne Marie Noronha, Roei David Mazor

Clin Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRAF3 suppression encourages B cell recruitment and prolongs survival of microbiome-intact mice with ovarian cancer.
Jonathan Zorea, Yair Motro, Roei D Mazor, Yifat Koren Carmi, Ziv Shulman

J Exp Clin Cancer Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosis.
Thibaud Chazal, Francesco Pegoraro, Gaia Manari, Alessandra Bettiol, Valerio Maniscalco, Roei D Mazor

Kidney Int· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-15a-5p acts as a tumor suppressor in histiocytosis by mediating CXCL10-ERK-LIN28a-let-7 axis.
Ran Weissman, Eli L Diamond, Julien Haroche, Benjamin H Durham, Fleur Cohen, Roei D Mazor

Leukemia· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-reactive antibodies evolve from non-binding and autoreactive precursors.
Roei D Mazor, Nachum Nathan, Amit Gilboa, Liat Stoler-Barak, Lihee Moss

Cell· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spillovers.
Shelley Klompus, Sigal Leviatan, Thomas Vogl, Roei D Mazor, Iris N Kalka

Sci Immunol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Contribution of MicroRNAs to the Inflammatory and Neoplastic Characteristics of Erdheim-Chester Disease.
Ran Weissman, Eli L Diamond, Julien Haroche, Nir Pillar, Guy Shapira, Roei D Mazor

Cancers (Basel)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era.
Gaurav Goyal, Mark L Heaney, Matthew Collin, Fleur Cohen-Aubart, Augusto Vaglio, Roei D Mazor

Blood· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual BRAF/MEK blockade restores CNS responses in BRAF-mutant Erdheim-Chester disease patients following BRAF inhibitor monotherapy.
Roei D Mazor, Ran Weissman, Judith Luckman, Liran Domachevsky, Eli L Diamond

Neurooncol Adv· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Added Value of Fetal MRI in the Evaluation of Fetal Anomalies of the Corpus Callosum: A Retrospective Analysis of 78 Cases.
Mirra Manevich-Mazor, Alina Weissmann-Brenner, Omer Bar Yosef, Chen Hoffmann, Roei David Mazor

Ultraschall Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ICAMs support B cell interactions with T follicular helper cells and promote clonal selection.
Irina Zaretsky, Ofir Atrakchi, Roei D Mazor, Liat Stoler-Barak, Adi Biram

J Exp Med· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects" [J. Autoimmun. 47C (2013) 1-16].
Carlo Perricone, Serena Colafrancesco, Roei D Mazor, Alessandra Soriano, Nancy Agmon-Levin

J Autoimmun· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The inter-observer variability of breast density scoring between mammography technologists and breast radiologists and its effect on the rate of adjuvant ultrasound.
Roei D Mazor, Avital Savir, David Gheorghiu, Yuliana Weinstein, Ifat Abadi-Korek

Eur J Radiol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series.
Roei D Mazor, Mirra Manevich-Mazor, Anat Kesler, Orna Aizenstein, Iris Eshed

BMC Med· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Erdheim-Chester disease].
Roei D Mazor, Yehuda Shoenfeld

Harefuah· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects.
Carlo Perricone, Serena Colafrancesco, Roei D Mazor, Alessandra Soriano, Nancy Agmon-Levin

J Autoimmun· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erdheim-Chester Disease: a comprehensive review of the literature.
Roei D Mazor, Mirra Manevich-Mazor, Yehuda Shoenfeld

Orphanet J Rare Dis· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erdheim-Chester disease: an orphan condition seeking treatment.
Roei D Mazor, Anat Kesler, Yehuda Shoenfeld

Isr Med Assoc J· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis